HOOKIPA Pharma (HOOK) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

HOOK HOOKIPA Pharma

Watchlist

1.890
-0.010-0.53%

Close Feb 14 16:00 ET

1.760
-0.130-6.88%

Post 20:01 ET

18.70MMarket Cap-0.51P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Hookipa Pharma Announces Enrollment Completion of Phase 1b HB-500 Trial
TipRanksJan 30 07:21 ET
Express News | HOOKIPA Pharma Inc - Primary Completion of Phase 1B Trial Expected H2 2025
ReutersJan 30 07:00 ET
Express News | HOOKIPA Pharma Announces Enrollment Completion of Phase 1B Clinical Trial Evaluating Hb-500 for the Treatment of Hiv
ReutersJan 30 07:00 ET
Poolbeg Agrees to Bid Deadline Extension for Possible Hookipa Pharma Deal
Dow JonesJan 30 04:51 ET
Hookipa Pharma Seeks Validation for Stockholder Meetings
TipRanksJan 29 08:30 ET
Gilead Sciences, Inc. UK Regulatory Announcement: Form 8.3 - HOOKIPA Pharma Inc.
BusinesswireJan 15 09:30 ET

Comments

Jaguar8

Jan 30 06:04

NEWS

$HOOKIPA Pharma (HOOK.US)$
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
3 minutes ago, 4:00 AM PST
Via GlobeNewswire
HOOK
Share
HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of a curative regimen for human immunodeficiency virus (HIV)
Under the collaboration agreement, HOOKIPA is responsible for advancing the HIV program throug...

GingleCash

Jan 13 05:59

Loading soon!

Share Your Profit/Loss

Sean Parker

Jan 10 02:06

Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA

$HOOKIPA Pharma (HOOK.US)$
Poolbeg Pharma and HOOKIPA Pharma have provided an update on their potential combination, following announcements from January 2 and 7, 2025. The key update concerns Gilead Sciences' participation in the proposed concurrent Fundraise. Gilead has expressed its intention to:
1. Vote in alignment with HOOKIPA Board's recommendation if a formal offer is m...

Jaguar8

Jan 10 01:01

NEWS

$HOOKIPA Pharma (HOOK.US)$
Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA
Poolbeg Pharma and HOOKIPA Pharmahave provided an update on their potential combination, following announcements from January 2 and 7, 2025. The key update concerns Gilead Sciences' participation in the proposed concurrent Fundraise. Gilead has expressed its intention to:
1. Vote in alignment with HOOKIPA Board's recommendation if a formal offer ...